Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Friday reported an increase in adjusted profit for the first quarter of 2025,
Cardinal Health Inc.
-(CAH)
XNYS:CAH
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2024 results
Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the fourth quarter
Cardinal Health Inc Q4 2023 Earnings Conference Call Insights
Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including its highest
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit. Revenues
Cardinal Health Inc (CAH) Q2 2023 Earnings Call Transcript
Cardinal Health Inc (NYSE: CAH) Q2 2023 earnings call dated Feb. 02, 2023 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Jason Hollar -- Chief
Cardinal Health Inc. (CAH) Q4 2022 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Cardinal Health Inc. (CAH) Q3 2022 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q3 2022 earnings call dated May. 05, 2022 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief
Cardinal Health, Inc. (CAH) Q2 2022 Earnings Call Transcript
Cardinal Health, Inc. (NYSE: CAH) Q2 2022 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Cardinal Health Inc. (CAH) Q3 2021 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q3 2021 earnings call May. 06, 2021. Corporate Participants: Kevin Moran -- Vice President of Investor Relations
Cardinal Health Inc. (CAH) Q2 2021 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q2 2021 earnings call dated Feb. 05, 2021 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Cardinal Health Inc. (CAH) Q1 2021 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q1 2021 earnings call dated Nov. 05, 2020 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief
Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Kevin Moran -- Vice President-Investor Relations Michael C. Kaufmann -- Chief
Cardinal Health Inc. (NYSE: CAH) Q3 2020 Earnings Call Transcript
Cardinal Health Inc. (CAH) Q3 2020 earnings call dated May 11, 2020 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief Executive
A visual representation of Cardinal Health’s (CAH) Q3 2020 earnings results
Cardinal Health (NYSE: CAH) reported third quarter 2020 earnings results today. Revenues amounted to $39.2 billion, up 11% year-over-year. GAAP EPS increased
Cardinal Health Inc (NYSE: CAH) Q2 2020 Earnings Call Transcript
Cardinal Health Inc (CAH) Q2 2020 earnings call dated Feb. 06, 2020 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike Kaufmann -- Chief
Cardinal Health (CAH) Q2 2020 Earnings Snapshot
-- Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected. -- Revenue increased
Cardinal Health (CAH): Q1 2020 Earnings Snapshot
-- Cardinal Health (NYSE: CAH) reported first-quarter 2020 earnings of $1.27 per share, vs. $1.09 per share expected. -- Total revenue rose
Catalent stock soars to record high
Catalent Inc. (CTLT) stock soared to a record high of $50.62 on Wednesday as investors were satisfied with the company's future after
Cardinal Health stock surges above 6% on Q2 earnings beat
Cardinal Health (NYSE: CAH) reported better-than-expected Q2 results primarily driven by better performance from the Pharmaceutical division. The company’s stock jumped above
Cardinal Health posts better-than-expected Q1 earnings
Cardinal Health Inc. (CAH) reported a 408% jump in earnings for the first quarter helped by a gain on disposal of naviHealth